Free Trial

Centene (CNC) Competitors

Centene logo
$29.14 -0.26 (-0.87%)
As of 02:51 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CNC vs. ELV, MOH, SEM, HUM, UNH, CI, JYNT, AEMD, EW, and TAK

Should you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Humana (HUM), UnitedHealth Group (UNH), Cigna Group (CI), Joint (JYNT), Aethlon Medical (AEMD), Edwards Lifesciences (EW), and Takeda Pharmaceutical (TAK). These companies are all part of the "medical" sector.

Centene vs. Its Competitors

Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.3% of Elevance Health shares are held by company insiders. Comparatively, 0.4% of Centene shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Elevance Health presently has a consensus target price of $413.81, suggesting a potential upside of 32.36%. Centene has a consensus target price of $42.20, suggesting a potential upside of 44.51%. Given Centene's higher possible upside, analysts clearly believe Centene is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
6 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.67
Centene
1 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.12

Elevance Health has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500.

Elevance Health has a net margin of 2.83% compared to Centene's net margin of 1.15%. Elevance Health's return on equity of 17.59% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.83% 17.59% 6.36%
Centene 1.15%9.57%3.10%

In the previous week, Centene had 61 more articles in the media than Elevance Health. MarketBeat recorded 96 mentions for Centene and 35 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.24 beat Centene's score of 0.38 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
26 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive
Centene
28 Very Positive mention(s)
8 Positive mention(s)
39 Neutral mention(s)
10 Negative mention(s)
4 Very Negative mention(s)
Neutral

Elevance Health has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$177.01B0.40$5.98B$23.5013.30
Centene$178.19B0.08$3.31B$4.047.23

Summary

Elevance Health beats Centene on 11 of the 16 factors compared between the two stocks.

Get Centene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNC vs. The Competition

MetricCenteneMED IndustryMedical SectorNYSE Exchange
Market Cap$14.33B$41.90B$5.76B$20.89B
Dividend YieldN/A100.37%4.53%3.60%
P/E Ratio7.2210.0930.4328.30
Price / Sales0.080.71392.2152.84
Price / Cash2.968.5437.0323.77
Price / Book0.522.349.015.18
Net Income$3.31B$2.64B$3.26B$992.10M
7 Day Performance8.43%15.68%1.00%-0.36%
1 Month Performance6.58%11.73%4.19%1.14%
1 Year Performance-62.75%-34.02%28.39%10.37%

Centene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNC
Centene
4.8571 of 5 stars
$29.15
-0.9%
$42.20
+44.8%
-62.4%$14.33B$178.19B7.2260,500Trending News
Analyst Revision
ELV
Elevance Health
4.8649 of 5 stars
$290.80
-1.1%
$418.19
+43.8%
-42.8%$65.48B$177.01B12.37104,200News Coverage
Positive News
MOH
Molina Healthcare
4.9452 of 5 stars
$153.84
-1.9%
$244.55
+59.0%
-50.1%$8.34B$43.41B7.5818,000Positive News
Short Interest ↑
SEM
Select Medical
4.9943 of 5 stars
$12.06
-0.1%
$24.60
+104.0%
-60.8%$1.50B$5.28B11.3844,100Analyst Revision
HUM
Humana
4.25 of 5 stars
$267.19
+0.2%
$281.62
+5.4%
-18.7%$32.13B$117.76B20.5165,680Positive News
Analyst Forecast
Analyst Revision
UNH
UnitedHealth Group
4.9616 of 5 stars
$252.44
+0.6%
$366.52
+45.2%
-48.4%$229.00B$422.82B10.94400,000Trending News
Analyst Forecast
CI
Cigna Group
4.9993 of 5 stars
$277.16
+0.8%
$377.72
+36.3%
-11.2%$73.98B$247.12B15.1373,500Positive News
Insider Trade
JYNT
Joint
4.0013 of 5 stars
$10.80
+0.6%
$16.33
+51.2%
-9.2%$165.24M$51.90M-32.73320Positive News
Insider Trade
AEMD
Aethlon Medical
2.4417 of 5 stars
$1.24
+0.8%
$56.00
+4,416.1%
-70.1%$3.21MN/A-0.1010Analyst Revision
Gap Up
EW
Edwards Lifesciences
4.4632 of 5 stars
$78.23
-0.2%
$85.90
+9.8%
+17.2%$45.93B$5.44B11.2615,800Positive News
Insider Trade
Analyst Revision
TAK
Takeda Pharmaceutical
1.543 of 5 stars
$14.43
-0.1%
N/A+4.8%$45.90B$30.09B48.0847,455News Coverage
Positive News
Short Interest ↑

Related Companies and Tools


This page (NYSE:CNC) was last updated on 8/21/2025 by MarketBeat.com Staff
From Our Partners